Class Action Lawsuit Against Zimmer Holdings Inc. Announced by The Brualdi Law Firm

NEW YORK, Aug. 8, 2008 (LAWFUEL) — The Brualdi Law Firm, P.C.
announces that a lawsuit has been commenced in the United States
District Court for the Southern District of Indiana on behalf of
purchasers of Zimmer Holdings, Inc. (“Zimmer” or “the Company”)
(NYSE:ZMH) common stock during the period between January 28, 2008 and
July 21, 2008 (the “Class Period”) for violations of federal securities
laws.

No class has yet been certified in the above action. Until a class is
certified, you are not represented by counsel unless you retain one. If
you purchased Zimmer common stock during the period described above,
you have certain rights, and have until no later than October 6, 2008
in which to move for Lead Plaintiff status. Any member of the purported
class may move the Court to serve as lead plaintiff through counsel of
their choice, or may choose to do nothing and remain an absent class
member.

To be a member of the class you need not take any action at this time,
and you may retain counsel of your choice. If you wish to discuss this
action or have any questions concerning this Notice or your rights or
interests with respect to these matters, please contact Sue Lee at The
Brualdi Law Firm, P.C. 29 Broadway, Suite 2400, New York, New York
10006, by telephone toll free at (877) 495-1187 or (212) 952-0602, by
email to [email protected] or visit our website at
http://www.brualdilawfirm.com.

The complaint alleges that during the Class Period, defendants
materially misrepresented the Company and its products. Specifically,
the complaint charges that defendants failed to disclose material flaws
in the quality systems at Zimmer’s Dover, Ohio facility, which
manufactured Zimmer Orthopedic Surgical Products. In addition,
defendants failed to disclose that patients receiving the Company’s
Durom Acetabular Component, used in total hip replacement procedures,
disproportionately experienced cup loosening requiring additional
corrective surgery after implantation. As a result of defendants’
materially false and misleading statements, Zimmer’s common stock
traded at artificially inflated prices during the Class Period. When
the true condition of the Company, its facilities, and its products
began to come to light, the price of Zimmer stock declined, falling
from $70.88 to $66.01 per share in one day.

Scroll to Top